• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能影响急性呼吸窘迫综合征预后的可调节因素:LUNG SAFE 研究。

Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study.

机构信息

Departments of Anesthesia and Critical Care Medicine, Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Canada.

Departments of Anesthesia, Physiology, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.

出版信息

Intensive Care Med. 2016 Dec;42(12):1865-1876. doi: 10.1007/s00134-016-4571-5. Epub 2016 Oct 18.

DOI:10.1007/s00134-016-4571-5
PMID:27757516
Abstract

PURPOSE

To improve the outcome of the acute respiratory distress syndrome (ARDS), one needs to identify potentially modifiable factors associated with mortality.

METHODS

The large observational study to understand the global impact of severe acute respiratory failure (LUNG SAFE) was an international, multicenter, prospective cohort study of patients with severe respiratory failure, conducted in the winter of 2014 in a convenience sample of 459 ICUs from 50 countries across five continents. A pre-specified secondary aim was to examine the factors associated with outcome. Analyses were restricted to patients (93.1 %) fulfilling ARDS criteria on day 1-2 who received invasive mechanical ventilation.

RESULTS

2377 patients were included in the analysis. Potentially modifiable factors associated with increased hospital mortality in multivariable analyses include lower PEEP, higher peak inspiratory, plateau, and driving pressures, and increased respiratory rate. The impact of tidal volume on outcome was unclear. Having fewer ICU beds was also associated with higher hospital mortality. Non-modifiable factors associated with worsened outcome from ARDS included older age, active neoplasm, hematologic neoplasm, and chronic liver failure. Severity of illness indices including lower pH, lower PaO/FiO ratio, and higher non-pulmonary SOFA score were associated with poorer outcome. Of the 578 (24.3 %) patients with a limitation of life-sustaining therapies or measures decision, 498 (86.0 %) died in hospital. Factors associated with increased likelihood of limitation of life-sustaining therapies or measures decision included older age, immunosuppression, neoplasia, lower pH and increased non-pulmonary SOFA scores.

CONCLUSIONS

Higher PEEP, lower peak, plateau, and driving pressures, and lower respiratory rate are associated with improved survival from ARDS.

TRIAL REGISTRATION

ClinicalTrials.gov NCT02010073.

摘要

目的

为了改善急性呼吸窘迫综合征(ARDS)的预后,需要确定与死亡率相关的潜在可改变因素。

方法

这项大型观察性研究旨在了解全球严重急性呼吸衰竭的影响(LUNG SAFE)是一项国际性、多中心、前瞻性队列研究,纳入了 2014 年冬季来自 5 大洲 50 个国家的 459 家 ICU 的 2377 例严重呼吸衰竭患者。一个预先设定的次要目标是研究与结局相关的因素。分析仅限于在第 1-2 天满足 ARDS 标准且接受有创机械通气的患者。

结果

潜在可改变的因素与多变量分析中增加的住院死亡率相关,包括较低的 PEEP、较高的峰压、平台压和驱动压以及较高的呼吸频率。潮气量对结局的影响尚不清楚。ICU 床位较少也与较高的住院死亡率相关。与 ARDS 预后恶化相关的不可改变因素包括年龄较大、活动性肿瘤、血液系统肿瘤和慢性肝功能衰竭。严重程度指数,包括较低的 pH 值、较低的 PaO/FiO 比值和较高的非肺部 SOFA 评分,与较差的预后相关。在 578 例(24.3%)有生命支持治疗或措施限制决策的患者中,有 498 例(86.0%)在医院死亡。与生命支持治疗或措施限制决策可能性增加相关的因素包括年龄较大、免疫抑制、肿瘤、较低的 pH 值和较高的非肺部 SOFA 评分。

结论

较高的 PEEP、较低的峰压、平台压和驱动压以及较低的呼吸频率与 ARDS 的生存率改善相关。

试验注册

ClinicalTrials.gov NCT02010073。

相似文献

1
Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study.可能影响急性呼吸窘迫综合征预后的可调节因素:LUNG SAFE 研究。
Intensive Care Med. 2016 Dec;42(12):1865-1876. doi: 10.1007/s00134-016-4571-5. Epub 2016 Oct 18.
2
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
3
The impact of a lung-protective ventilation mode using transpulmonary driving pressure titrated positive end-expiratory pressure on the prognosis of patients with acute respiratory distress syndrome.使用经肺驱动压滴定呼气末正压的肺保护性通气模式对急性呼吸窘迫综合征患者预后的影响。
J Clin Monit Comput. 2024 Dec;38(6):1405-1414. doi: 10.1007/s10877-024-01198-3. Epub 2024 Aug 19.
4
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies.四项观察性研究的 pooled 分析:无急性呼吸窘迫综合征的侵入性通气重症监护病房患者的流行病学、通气管理和结局的地缘经济学差异。
Lancet Glob Health. 2022 Feb;10(2):e227-e235. doi: 10.1016/S2214-109X(21)00485-X. Epub 2021 Dec 13.
5
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局:一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.
6
Adherence to Lung-Protective Ventilation Principles in Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study.肺保护性通气原则在小儿急性呼吸窘迫综合征中的应用:小儿急性呼吸窘迫综合征发生率和流行病学研究。
Crit Care Med. 2021 Oct 1;49(10):1779-1789. doi: 10.1097/CCM.0000000000005060.
7
Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database.免疫功能低下的急性呼吸窘迫综合征患者:LUNG SAFE 数据库的二次分析。
Crit Care. 2018 Jun 12;22(1):157. doi: 10.1186/s13054-018-2079-9.
8
Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.16 个国家重症监护病房急性呼吸窘迫综合征高危患者的流行病学特征、通气实践和临床转归(PRoVENT):一项国际多中心前瞻性研究。
Lancet Respir Med. 2016 Nov;4(11):882-893. doi: 10.1016/S2213-2600(16)30305-8. Epub 2016 Oct 4.
9
Epidemiology, Mechanical Power, and 3-Year Outcomes in Acute Respiratory Distress Syndrome Patients Using Standardized Screening. An Observational Cohort Study.标准化筛查在急性呼吸窘迫综合征患者中的流行病学、机械动力和 3 年结局:一项观察性队列研究。
Ann Am Thorac Soc. 2019 Oct;16(10):1263-1272. doi: 10.1513/AnnalsATS.201812-910OC.
10
Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts.欧洲重症监护病房急性呼吸窘迫综合征的流行病学、治疗方法和预后的时间变化:两个大队列的比较。
Crit Care. 2021 Feb 25;25(1):87. doi: 10.1186/s13054-020-03455-8.

引用本文的文献

1
Impact of proning with and without inhaled pulmonary vasodilators and neuromuscular blocking agents in COVID acute respiratory distress syndrome.在新冠急性呼吸窘迫综合征中,使用和不使用吸入性肺血管扩张剂及神经肌肉阻滞剂进行俯卧位通气的影响。
World J Crit Care Med. 2025 Sep 9;14(3):101327. doi: 10.5492/wjccm.v14.i3.101327.
2
[S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].[S3 脓毒症预防、诊断、治疗及随访指南 - 2025年更新版]
Med Klin Intensivmed Notfmed. 2025 Aug 18. doi: 10.1007/s00063-025-01317-1.
3
Severe ARDS Complicated by Active Pulmonary Tuberculosis and Recurrent Nosocomial Infections: Therapeutic Challenges and Clinical Outcomes.

本文引用的文献

1
Withholding and withdrawal of life-sustaining treatments in low-middle-income versus high-income Asian countries and regions.中低收入亚洲国家和地区与高收入亚洲国家和地区之间的生命维持治疗的保留和撤销。
Intensive Care Med. 2016 Jul;42(7):1118-27. doi: 10.1007/s00134-016-4347-y. Epub 2016 Apr 12.
2
Guidelines for the withdrawal of life-sustaining measures.生命维持措施退出指南。
Intensive Care Med. 2016 Jun;42(6):1003-17. doi: 10.1007/s00134-016-4330-7. Epub 2016 Apr 8.
3
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
重症急性呼吸窘迫综合征合并活动性肺结核及反复医院感染:治疗挑战与临床结局
Life (Basel). 2025 Jul 4;15(7):1068. doi: 10.3390/life15071068.
4
Effect of decreasing respiratory rate on the mechanical power of ventilation and lung injury biomarkers: a randomized cross-over clinical study in COVID-19 ARDS patients.降低呼吸频率对通气机械功率和肺损伤生物标志物的影响:一项针对新型冠状病毒肺炎急性呼吸窘迫综合征患者的随机交叉临床研究
Intensive Care Med Exp. 2025 Jul 9;13(1):69. doi: 10.1186/s40635-025-00782-4.
5
Evaluating the Preparedness of Healthcare Providers for Prone Position CPR Across Jordan's Healthcare Sectors: A Descriptive Cross-Sectional Study.评估约旦各医疗保健部门的医护人员对俯卧位心肺复苏的准备情况:一项描述性横断面研究。
Health Sci Rep. 2025 Jul 2;8(7):e70955. doi: 10.1002/hsr2.70955. eCollection 2025 Jul.
6
Vagus Nerve Stimulation Regulates the Th17/Treg Balance and Alleviates Lung Injury in Acute Respiratory Distress Syndrome by Upregulating α7nAChR.迷走神经刺激通过上调α7烟碱型乙酰胆碱受体调节Th17/Treg平衡并减轻急性呼吸窘迫综合征中的肺损伤。
Biomedicines. 2025 May 24;13(6):1294. doi: 10.3390/biomedicines13061294.
7
Driving pressure in acute respiratory distress syndrome for developing a protective lung strategy: A systematic review.急性呼吸窘迫综合征中驱动压对制定肺保护策略的影响:一项系统评价。
World J Crit Care Med. 2025 Jun 9;14(2):101377. doi: 10.5492/wjccm.v14.i2.101377.
8
Diagnostic performance of the recruitment-to-inflation ratio to assess lung recruitability by PEEP in ARDS. a computed tomography study.通过PEEP评估ARDS中肺可复张性的肺复张与膨胀比的诊断性能:一项计算机断层扫描研究
Crit Care. 2025 Jun 3;29(1):220. doi: 10.1186/s13054-025-05453-0.
9
Factors influencing the transition phase in acute respiratory distress syndrome: an observational cohort study.影响急性呼吸窘迫综合征过渡阶段的因素:一项观察性队列研究。
Ann Intensive Care. 2025 May 26;15(1):71. doi: 10.1186/s13613-025-01484-6.
10
Partial arterial carbon dioxide and oxygen pressure in patients with cardiogenic shock.心源性休克患者的动脉血二氧化碳分压和氧分压
Intern Emerg Med. 2025 Jun;20(4):1077-1086. doi: 10.1007/s11739-025-03926-2. Epub 2025 May 9.
全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
4
Mechanical Power and Development of Ventilator-induced Lung Injury.机械功率与呼吸机相关性肺损伤的发展
Anesthesiology. 2016 May;124(5):1100-8. doi: 10.1097/ALN.0000000000001056.
5
Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress sindrome.低流量体外二氧化碳清除促进中度急性呼吸窘迫综合征患者超保护性通气的可行性和安全性。
Crit Care. 2016 Feb 10;20:36. doi: 10.1186/s13054-016-1211-y.
6
Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.不升级治疗、不维持和停止生命维持治疗对 ICU 患者预后的各自影响:Outcomerea 研究组的多中心研究。
Intensive Care Med. 2015 Oct;41(10):1763-72. doi: 10.1007/s00134-015-3944-5. Epub 2015 Jul 7.
7
Driving pressure and survival in the acute respiratory distress syndrome.驱动压与急性呼吸窘迫综合征患者的生存。
N Engl J Med. 2015 Feb 19;372(8):747-55. doi: 10.1056/NEJMsa1410639.
8
Low respiratory rate plus minimally invasive extracorporeal Co2 removal decreases systemic and pulmonary inflammatory mediators in experimental Acute Respiratory Distress Syndrome.低呼吸频率加微创体外 CO2 去除可减少实验性急性呼吸窘迫综合征中的全身和肺炎症介质。
Crit Care Med. 2014 Jun;42(6):e451-60. doi: 10.1097/CCM.0000000000000312.
9
Spontaneous breathing, extrapulmonary CO(2) removal, and ventilator-induced lung injury risk: less power to the people?*.自主呼吸、肺外二氧化碳清除与呼吸机诱发肺损伤风险:让患者自主呼吸的能力减弱了?*
Crit Care Med. 2014 Mar;42(3):758-60. doi: 10.1097/CCM.0000000000000206.
10
Prone positioning in severe acute respiratory distress syndrome.俯卧位通气治疗严重急性呼吸窘迫综合征。
N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20.